SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2019 Baltimore, MD
Activity/Course #:
: 05.18.19PC

Cost:
: Free
Release/Start Date:
: May 18 2019
Expiration Date:
: May 18 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 6.0 hours
Credit(s):
: 6.0 AMA PRA Category I Credit(s)
6.0 AANP Contact hour(s) which includes 1.5 pharmacology hour(s)
Hardware/Software Requirements:

Saturday, May 18, 2019
Hilton Baltimore

401 W. Pratt Street
Baltimore, MD 21201
(443) 573-8700

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking


A self-parking rate of $32.00 is available at the hotel. A self-parking rate of $17.00 is available at the Redwood Garage located at 11 S. Eutaw Street which is a 4 minute walk away.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Demonstrate understanding of the burden and epidemiology surrounding HIV risk and transmission; Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis for the Prevention of HIV Prevention in the United States to appropriately screen and determine eligibility for PrEP; Initiate a patient-provider dialog regarding sexual health and a sexual behavior assessment; Implement appropriate HIV-prevention strategies for initiation and monitoring of patients on PrEP.
  2. Recognize the pervasive nature and global impact of ADHD symptoms throughout the day; Describe the physical and psychologic morbidity and mortality associated with ADHD; Use ADHD assessment tools to aid in diagnosis, track, and measure changes in ADHD symptoms to optimize pharmacologic treatment, non-pharmacologic treatment, and symptom control throughout the day; Implement appropriate and individualized treatment regimens for patients with ADHD.
  3. Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.
  4. Recognize the association between hypertriglyceridemia and atherosclerotic cardiovascular disease (ASCVD); Discuss the different biologic properties of omega-3 fatty acids and their impact on lipid levels; Identify patients who might benefit from triglyceride lowering; Utilize evidence-based approaches to manage patients with hypertriglyceridemia.
  5. Describe nocturia’s impact on affected patients; Evaluate symptoms of Nocturia in affected patients in order to determine the source of symptoms; Assess current pharmacologic and non-pharmacologic nocturia management strategies; Differentiate the mechanisms of action, and safety and efficacy profiles of available and emerging therapies for nocturia.
 

Agenda*

7:30-8:00 am
        
Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Jack Kravitz, MD
8:10-9:20   Getting PrEP’d to Talk About Sexual Health: Optimizing the PCP’s Role in HIV
Prevention
Jason Halperin, MD, MPH
9:20-10:30
 Bringing ADHD into Focus: Strategies for Individualizing Care
C. Brendan Montano, MD

10:30-10:50
 Break
10:50-12:00   A Case Based Approach to Lipids Management: Individualizing Targets and Reducing Risk
Karol Watson, MD, PhD
12:00-1:10   Lunch (on your own)
1:10-2:20 pm
  Cardiovascular Disease and Hypertriglyceridemia: The Evolving Link
Karol Watson, MD, PhD
2:20-3:30
  Identification, Evaluation and Treatment of Nocturia in the Primary Care Setting in 2019
Matt T. Rosenberg, MD
3:30-3:45   Summary of Key Points and Closing Remarks
Jack Kravitz, MD

*Agenda subject to change.

Faculty

Jason Halperin, MD, MPH
Assistant Professor of Medicine
Tulane University
Infectious Disease
Physician, CrescentCare
New Orleans, LA

C. Brendan Montano, MD
Private Practice, Internal Medicine
Director, Connecticut Clinical Research
Farmington, CT

Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
Los Angeles, CA

Moderator

Jack Kravitz, MD
Family Practice - Geriatrics
Coral Springs, FL


Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education

Plantation, FL

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

Rose O’Connor, PhD, CHCP
Director, Scientific Services
Integritas Communications Group
Hoboken, NJ

Stacey JP Ullman, MHS
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ 

Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates 
San Francisco, CA

Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6.0 contact hours of continuing education, which includes 1.5 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This educational activity is supported by an educational grant from Gilead Sciences, Inc; educational funding provided by Amgen; an independent medical educational grant from Shire; in part by an educational grant from Ferring Pharmaceuticals, Inc.; and an educational grant from Amarin Pharma Inc.